15-Year Followup of a Population Based Prostate Cancer Screening Study

被引:67
作者
Kiellman, Anders [1 ]
Akre, Olof [2 ,4 ]
Norming, Ulf [3 ]
Tornblom, Magnus [3 ]
Gustafsson, Ove [1 ]
机构
[1] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden
[2] Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden
[3] Karolinska Inst, Sodersjukhuset, Dept Clin Sci & Educ, Stockholm, Sweden
[4] Univ Turin, Ctr Oncol Prevent Piemonte, Canc Epidemiol Unit, Ctr Expt Res & Med Studies, Turin, Italy
关键词
prostate; prostatic neoplasms; mortality; outcome assessment (health care); mass screening; NON-ATTENDANCE; REGISTER; TRIAL; DEATH; LUNG;
D O I
10.1016/j.juro.2008.11.115
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We evaluated long-term survival in attendees and nonattendees of a 1-time screening for prostate cancer. Materials and Methods: A total of 2,400 men 55 to 70 years old in 1988 were randomly selected and invited to a screening for prostate cancer. Of the invited men 1,782 (74%) attended, Screening attendees were examined with digital rectal examination, transrectal ultrasound and prostate specific antigen analysis. When cancer was suspected, prostate biopsies were taken. A total of 65 men with prostate cancer were detected by this procedure. The entire source population comprising 27,204 men, including 618 nonattendees (26%), was followed for prostate cancer diagnosis and survival for 15 years. Results: Incidence rate ratios were calculated using Poisson regression models. We found no effect of this screening procedure on the risk of death from prostate cancer and other causes of death (incidence rate ratio 1.10, 95% CI 0.83-1.46 and 0.98, 95% CI 0.92-1.05, respectively) when comparing all invited men with the source population. However, attending the screening program was associated with a significantly decreased risk of death from causes other than prostate cancer (vs source population incidence rate ratio 0.82, 95% CI 0.76-0.90). In contrast, the corresponding incidence rate ratio in nonattendees was 1.53 (95% CI 1.37-1.71). Conclusions: We found no evidence of a beneficial effect of this specific screening procedure but strong evidence of a difference in overall survival in screening attendees and nonattendees. These findings should be considered when interpreting previous and upcoming studies of the effect of screening programs.
引用
收藏
页码:1615 / 1621
页数:7
相关论文
共 18 条
[1]  
BEISLAND HO, 1990, ANN CHIR GYNAECOL FE, V79, P200
[2]   Large-scale randomized prostate cancer screening trials:: Program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trial [J].
de Koning, HJ ;
Auvinen, A ;
Sanchez, AB ;
da Silva, FC ;
Ciatto, S ;
Denis, L ;
Gohagan, JK ;
Hakama, M ;
Hugosson, J ;
Kranse, R ;
Nelen, V ;
Prorok, PC ;
Schröder, FH .
INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (02) :237-244
[3]   DIAGNOSTIC METHODS IN THE DETECTION OF PROSTATE-CANCER - A STUDY OF A RANDOMLY SELECTED POPULATION OF 2,400 MEN [J].
GUSTAFSSON, O ;
NORMING, U ;
ALMGARD, LE ;
FREDRIKSSON, A ;
GUSTAVSSON, G ;
HARVIG, B ;
NYMAN, CR .
JOURNAL OF UROLOGY, 1992, 148 (06) :1827-1831
[4]   MALIGNANT DISEASE OBSERVED IN A COHORT OF WOMEN - A VALIDATION OF SWEDISH-CANCER-REGISTRY DATA [J].
HELGESSON, O ;
BENGTSSON, C ;
LAPIDUS, L ;
MERCK, C ;
SPAREN, P .
SCANDINAVIAN JOURNAL OF SOCIAL MEDICINE, 1994, 22 (01) :46-49
[5]   Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinoma [J].
Hugosson, J ;
Aus, G ;
Lilja, H ;
Lodding, P ;
Pihl, CG .
CANCER, 2004, 100 (07) :1397-1405
[6]   Screening for prostate cancer: A Cochrane systematic review [J].
Ilic, Dragan ;
O'Connor, Denise ;
Green, Sally ;
Wilt, Timothy .
CANCER CAUSES & CONTROL, 2007, 18 (03) :279-285
[7]   Dihydrotestosterone levels and survival in screening-detected prostate cancer:: A 15-yr follow-up study [J].
Kiellman, Anders ;
Akre, Olof ;
Norming, Ulf ;
Toernblom, Magnus ;
Gustafsson, Ove .
EUROPEAN UROLOGY, 2008, 53 (01) :106-111
[8]  
Labrie F, 1999, PROSTATE, V38, P83, DOI 10.1002/(SICI)1097-0045(19990201)38:2<83::AID-PROS1>3.0.CO
[9]  
2-B
[10]   Sociodemographic predictors of non-attendance at invitational mammography screening - a population-based register study (Sweden) [J].
Lagerlund, M ;
Maxwell, AE ;
Bastani, R ;
Thurfjell, E ;
Ekbom, A ;
Lambe, M .
CANCER CAUSES & CONTROL, 2002, 13 (01) :73-82